Amendment No. 7 to Schedule 13G by Fairmount Funds Management LLC

Fairmount Funds Management LLC has filed Amendment No. 7 to Schedule 13G, reporting its ownership of shares in Astria Therapeutics, Inc. As of October 14, 2025, Fairmount Funds Management LLC holds 650,000 Pre-Funded Warrants and 1,727,049 common warrants, which could be converted into shares of Common Stock. The total beneficial ownership is 2,377,049 shares, representing 4.0% of the outstanding shares. The filing indicates a decrease in shares owned compared to previous filings, with a value change of $8,547,407.89 and a shares change of -1,177,080. The filing is made under Rule 13d-1(c) and includes certifications that the securities were not acquired for the purpose of influencing the control of the issuer.